This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bad Medicine Hits the IPO Market

The initial public offering market for health care ended the year in much the same way it behaved throughout 2004 -- lots of deals and lots of disappointments.

The good news is that underwriters engineered 50 public offerings of medical companies in 2004, which is more than the combined total of 44 from the prior three years.

The not-so-good news is that of those 50 IPOs, underwriters cut offering prices on a whopping 60% of the issues to bring them to market, according to Greenwich, Conn.-based Renaissance Capital. For all other IPOs, the rate of discounted offerings was 29.5%.

"The only IPO market faux pas was the medical market," said David Menlow, president of IPO Financial Network in Millburn, N.J. "It was a very trying time for us to see this force-feeding of issues" by underwriters. "Investors didn't want these deals at those prices."

Many discounted deals involved biotech companies; some IPOs were discounted more than once before finding willing investors. Many of those health care IPO offering prices were more than 40% below the initial range.

Renaissance Capital calculates the discount by dividing the offering price by the midpoint in the original price range. Thus, Memory Pharmaceuticals (MEMY), which had a $7 offering price, went public at 50% below the midpoint of its original price range of $13 to $15.

Memory was one of 30 medical IPOs that hit the market below their original price ranges. In fact, 14 of the 15 IPOs with the biggest rates of discounted offering prices were health care companies.

For medical companies, "2004 was a good year in general because they were able to raise money," said Melanie Hase, a Renaissance Capital analyst. "But the negative was that companies in early-stage testing of products were priced at a discount. It was great that investors were willing to invest, but they weren't willing to take such a risk at an early stage."

Healthy Returns
The best-performing health care IPOs in 2004
Company & Ticker Dec. 29 Closing Price Change From Offering Price
Kinetic Concepts (KCI) $75.93 +153.1%
Syneron Medical (ELOS) 30.18 151.5
Eyetech Pharmaceuticals (EYET) 45.27 115.6
Source: Renaissance Capital

Stock Market Ills
The worst-performing health care IPOs in 2004
Company & Ticker Dec. 29 Closing Price Change From Offering Price
Xcyte Therapies (XCYT) $2.66 -66.8%
Corgentech (CGTK) 8.11 -49.3
Corcept Therapeutics (CORT) 6.75 -43.8
Source: Renaissance Capital

Seventeen health care IPOs, or 34% of the total, went public at prices above their original price range. Among other IPOs, the rate of offering prices exceeding their price ranges was 13.9%.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs